基本信息
views: 156
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
作为项目负责人先后主持国家重点研发计划青年项目、广东省自然基金卓越青年团队项目、国家自然基金科学基金国际合作及面上、广东省自然科学基金杰出青年基金等10多项课题。获中国药理学会施维雅青年药理学家奖等奖项。近五年以通讯及第一作者在PNAS、Nat Commun、Nucleic Acid Res等SCI期刊发表论文60余篇。通讯及第一作者论文总计影响因子超过500,其中18篇IF>10,3篇文章入选ESI高被引论文。总计引用次数超过5500次,h-index为45,入选全球顶尖前10万科学家,全球前2%顶尖科学家榜单。国家重大人才工程、国家重点研发计划、国家自然科学基金、教育部科技发展中心等会评或函评专家。被国际知名SCI杂志如Adv Sci, STTT等邀请为审稿人,并任《Acta Pharmaceutica Sinica B》青年编委、中国抗癌协会肿瘤胃肠病学专委会青年副主委、中国药理学会抗炎免疫专委会青年常委等学术职务。
Research Interests
Papers共 155 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CELL DEATH & DISEASEno. 3 (2024)
Jiawang Zhou,Haisheng Zhang,Ke Zhong, Lijun Tao, Yu Lin,Guoyou Xie, Yonghuang Tan,You Wu, Yunqing Lu,Zhuojia Chen,Jiexin Li,Xin Deng,
NATIONAL SCIENCE REVIEWno. 3 (2024): nwae039-nwae039
SCIENCE CHINA-LIFE SCIENCESno. 4 (2024): 832-835
Science bulletinno. 6 (2024): 722-726
Feng Shu,Hao Liu,Xiaohui Chen,Ye Liu, Jiangli Zhou, Lei Tang, Wanwei Cao,Shanshan Yang, Yili Long, Rongna Li,Hao Wang,Hongsheng Wang,
Cancer researchno. 12 (2024): 1947-1962
Guoyou Xie, Yunqing Lu, Jiaxin He, Xianyuan Yang,Jiawang Zhou, Cheng Yi, Jian Li, Zigang Li,Gholamreza Asadikaram, Hongxin Niu,Xiaofeng Xiong,Jiexin Li,
Angewandte Chemie (International ed. in English)no. 26 (2024): e202320029-e202320029
Zhuojia Chen,Jiawang Zhou,You Wu,Feng Chen,Jianing Li, Lijun Tao, Yifan Tian, Haoran Wang,Jiexin Li,Zigang Li,Weiling He,Kun Zhang,
Oncogeneno. 13 (2024): 976-991
Cell Death & Diseaseno. 3 (2024): 1-16
THERANOSTICSno. 12 (2023): 3964-3965
Cited0Views0Bibtex
0
0
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn